Abbott pens blood-based Alzheimer’s testing pact with ALZpath Novartis is paying $105m upfront to task Antares Therapeutics with generating small molecules against historically undruggable oncology targets. H.B. Fuller, the largest adhesives company in the world, has made an offer to acquire Advanced…
Read More
Neurostimulation, AI for Drug Discovery, X-ray technology + Orthopaedics and more. All covered in my Monday deals summary from the worlds of Medtech and Biotech. 🔔 Helmed by Sanofi veteran, Bionyra emerges with $165m and three licensed I&I assets 🔔In another biotech…
Read MorePlenty of news to bring you across medical devices and biotech this morning. Deal news incldes headlings from neuromodulation, protein degraders, sleep technology, and more. Congratulations to all involved. ➡️ Swiss medtech CeQur has raised $100m in a new series E funding…
Read More
Parabilis Medicines is gearing up for an IPO that could eventually bring in as much as $476m to fund the phase 3 development of its desmoid tumor prospect. British medtech startup IMU Biosciences has landed a £40m series A as it…
Read More
Good morning, everyone. Plenty of headlines to bring you this week, with deals and IPOs across medical devices and biotech. Headlines include longevity, diagnostics, more AI, and endoscopy. Let me know if I missed any. ➡️ Pfizer is paying Innovent $650m upfront…
Read MoreBy continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.